Basque enterprise blog Entrepreneurship

Today Columbus Venture Partners announces the creation of Syngoi Technologies, a biotechnology company engaged in the production of synthetic DNA through a new enzymatic process, owned by the company, that addresses the needs of advanced therapies where DNA is the fundamental starting material. This is the case of gene therapy and mRNA-based vaccines, emerging therapeutic strategies where manufacturing is an important bottleneck. Syngoi has its own technology for the manufacture of its optimised synthetic DNA (orDNATM) which confers multiple...Read more

Next January the Participants will be announced and the acceleration program will begin. 20 of the Finalists selected are from Basque Country, 20 come from throughout Spain and 32 are International. This year, the Partner Companies are showing interest in projects related to IoT, Big Data, Advanced Analytics, Artificial Intelligence, Artificial Vision and Robotics, among other technologies.   BIND 4.0 and the 57 Corporate Partner companies that participate in this smart industry innovation platform, maintain their goals for...Read more

Entrepreneurship 28 May, 2020
The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN

The Basque Government  is engaged in the international project to make this production possible in the Basque Country Tapia highlights...Read more

Entrepreneurship 13 March, 2020
El Gobierno Vasco habilitará el martes nuevas iniciativas de apoyo a la mejora competitiva e intensificará ayudas a la recuperación de la economía productiva

La industria vasca prevé una afección global a corto-largo plazo imposible aún de cuantificar, aunque su producción todavía se...Read more

Entrepreneurship 3 February, 2020
VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)

AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D After the...Read more

Entrepreneurship 2 October, 2019
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan

  VIVEbiotech has carried out a capital increase of 3.5 million euros to finance its strategic plan, which highlights the...Read more

f2p Campus araba alava gasteiz vitoria
Entrepreneurship 19 July, 2019
The second edition of the F2P Campus in Vitoria-Gasteiz begins

After months of preparation, today the second edition of the F2P Campus, the world’s first campus focused on the development of...Read more

Hristo-Ognyanov make it global
Entrepreneurship 12 July, 2019
InterMundos – make it global: the difference between “good content” and “great content”

Bulgarian by birth, he was raised in the “country of roses” until he was a teenager and then studied abroad. Hristo Ognyanov Velikov...Read more

Entrepreneurship 17 June, 2019
VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the...Read more

Digitalisation 12 March, 2019
In Cannes, the SPRI Group General Manager receives the Financial Times award for the Basque Country as an attractive region for foreign investment

  Four aspects of the Invest in the Basque Country strategy of the SPRI Group and the Basque Government have received...Read more

  • Share
Subscribe to our newsletter and receive it by email Write your email address here to subscribe // Subscribe

Únete a más profesionales como tú

Síguenos y recibe en tu Linkedin información diaria segmentada
por sectores de actividad y países de interés para tomar las
decisiones más competitivas

Súmate, somos una red imparable

If you weren’t able to attend

you can check out the key points on our YouTube channel

Networkingzone


Find the professionals that have
attended the same events as you.
We’re sure you’ll have so much to talk about.

Log in to your agenda.spri.eus
profile and strengthen your network

Register Log in to your profile